The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer before and after Cystectomy Depending on Blood Group and Neoadjuvant Chemotherapy-A Multicentre Retrospective Cohort Study.
Emma Schulz HägerstenKristoffer OttossonSofia PelanderMarkus JohanssonYlva HugeFiras AljaberyFarhood AlamdariJohan SvenssonJohan StyrkeAmir SherifPublished in: Journal of personalized medicine (2023)
No significant associations were found between blood types and TEE occurrences in this cohort including both NAC and NAC-naïve NAC-eligible patients.
Keyphrases
- neoadjuvant chemotherapy
- transcription factor
- muscle invasive bladder cancer
- end stage renal disease
- locally advanced
- lymph node
- ejection fraction
- sentinel lymph node
- newly diagnosed
- chronic kidney disease
- clinical trial
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- squamous cell carcinoma
- robot assisted
- study protocol